Friday, March 18, 2016

UPDATE 1-Vectura to buy SkyePharma for $620 mln as UK biotech consolidates

* Combined group market value more than 1 billion pounds

(Adds more on rationale for deal, comment from CEO)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)